Grifols SA (GRFS)

7.315 +0.12 (+1.60%) USD  |  NASDAQ  |  Sep 25, 12:48
More

Grifols Cash and Short Term Investments (Quarterly) : 586.51M for June 30, 2026

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for GRFS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2006. Start Trial.
Date Value
June 30, 2026 586.51M
March 31, 2026 808.84M
December 31, 2025 968.92M
September 30, 2025 729.63M
June 30, 2025 655.82M
March 31, 2025 813.19M
December 31, 2024 1.015B
September 30, 2024 719.79M
June 30, 2024 2.265B
March 31, 2024 484.43M
December 31, 2023 585.00M
September 30, 2023 512.67M
June 30, 2023 571.09M
March 31, 2023 462.45M
December 31, 2022
September 30, 2022
June 30, 2022
March 31, 2022
December 31, 2021
September 30, 2021
June 30, 2021
March 31, 2021 447.77M
December 31, 2020 709.23M
September 30, 2020 1.212B
June 30, 2020 986.58M
Date Value
March 31, 2020 699.71M
December 31, 2019 2.760B
September 30, 2019 863.58M
June 30, 2019 630.55M
March 31, 2019 647.56M
December 31, 2018 1.182B
September 30, 2018 676.00M
June 30, 2018 790.52M
March 31, 2018 1.041B
December 31, 2017 1.065B
September 30, 2017 963.63M
June 30, 2017 855.66M
March 31, 2017 788.57M
December 31, 2016 944.01M
September 30, 2016 1.012B
June 30, 2016 897.69M
March 31, 2016 1.148B
December 31, 2015 1.241B
September 30, 2015 995.53M
June 30, 2015 878.81M
March 31, 2015 856.81M
December 31, 2014 1.306B
September 30, 2014 1.159B
June 30, 2014 1.009B
March 31, 2014 944.23M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
argenx SE --
Evaxion AS 14.00M
Autolus Therapeutics Plc 203.13M
Pharma Mar SA 193.08M
Oryzon Genomics SA 16.79M